Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
32 hedge funds and large institutions have $6.14M invested in Acer Therapeutics Inc in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 3 closing their positions.
497% more call options, than puts
Call options by funds: $203K | Put options by funds: $34K
177% more capital invested
Capital invested by funds: $2.22M → $6.14M (+$3.92M)
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
14% more funds holding
Funds holding: 28 → 32 (+4)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$909K |
| 2 |
DMKJ
David M. Knott Jr
|
+$240K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$223K |
| 4 |
MWM
Meridian Wealth Management
Lexington,
Kentucky
|
+$123K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$103K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$88K |
| 2 |
CF
Copperwynd Financial
Scottsdale,
Arizona
|
-$65K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$23K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$15.8K |
| 5 |
Renaissance Technologies
New York
|
-$15.6K |
ACER Hedge Fund Activity: Q4 2022 in Review
32 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q4 2022, worth a combined $6.14M — up 177% from $2.22M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ACER positions and 3 closed out — a net gain of 4 holders — while 7 added to existing stakes and 9 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $909K. The largest seller was Citadel Advisors, cutting an estimated $88K.
- 32 institutional investors held Acer Therapeutics Inc (ACER) as of Q4 2022, up from 28 in Q3 2022.
- Funds reported $6.14M of Acer Therapeutics Inc stock for Q4 2022, up 177% quarter-over-quarter.
- 7 funds opened new Acer Therapeutics Inc positions in Q4 2022 and 3 closed out, a net change of +4 holders.
- The largest Acer Therapeutics Inc buyer in Q4 2022 was Nantahala Capital Management, an estimated $909K added.
- The largest Acer Therapeutics Inc seller in Q4 2022 was Citadel Advisors, an estimated $88K sold.
Based on aggregated 13F filings for Q4 2022.